Dr. Geetika Srivastava leads Project Asha to transform Oncology Clinical Trials in India

The goal of this collaboration is to identify short- and long-term opportunities for bilateral cancer cooperation that will drive greater care and improved outcomes for cancer patients.

Dr. Geetika Srivastava / FDA:

Dr. Geetika Srivastava, a prominent Indian American physician, has taken the reins of Project Asha, a groundbreaking initiative by the Food and Drug Administration (FDA) in collaboration with the White House Cancer Moonshot Program. This initiative aims to revolutionize oncology clinical trials in India, addressing critical gaps in access and research.

The impetus for Project Asha stems from the historic Official State visit of Prime Minister Narendra Modi to the United States in June 2023. During this pivotal diplomatic engagement, US President Joe Biden and Prime Minister Modi announced commitments to tackle cancer challenges, setting the stage for transformative initiatives like Project Asha.

Dr. Srivastava's leadership brings a wealth of expertise as a hematologist-medical oncologist and FDA medical officer, positioning Project Asha to drive meaningful change in cancer care. The project's core mission includes enhancing access to cutting-edge oncology trials, fostering regulatory cooperation, and empowering local researchers and clinicians through comprehensive training programs.

Project Asha under Dr. Srivastava's guidance promises to usher in a new era of progress and collaboration, with far-reaching implications for cancer care in India and beyond.








E Paper